Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 19:4:155.
doi: 10.3389/fimmu.2013.00155. eCollection 2013.

Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function

Jérémie David Goldstein  1 , Louis Pérol, Bruno Zaragoza, Audrey Baeyens, Gilles Marodon, Eliane Piaggio
Affiliations

Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function

Jérémie David Goldstein et al. Front Immunol. .

Abstract

CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) are essential players in the control of immune responses. Recently, accordingly to their origin, two main subsets of Tregs have been described: thymus-derived Tregs (tTregs) and peripherally derived Tregs (pTregs). Numerous signaling pathways including the IL-2/STAT5 or the TGF-β/Smad3 pathways play a crucial role in segregating the two lineages. Here, we review some of the information existing on the distinct requirements of IL-2, TGF-β, and TNF-α three major cytokines involved in tTreg and pTreg generation, homeostasis and function. Today it is clear that signaling via the IL-2Rβ chain (CD122) common to IL-2 and IL-15 is required for proper differentiation of tTregs and for tTreg and pTreg survival in the periphery. This notion has led to the development of promising therapeutic strategies based on low-dose IL-2 administration to boost the patients' own Treg compartment and dampen autoimmunity and inflammation. Also, solid evidence points to TGF-β as the master regulator of pTreg differentiation and homeostasis. However, therapeutic administration of TGF-β is difficult to implement due to toxicity and safety issues. Knowledge on the role of TNF-α on the biology of Tregs is fragmentary and inconsistent between mice and humans. Moreover, emerging results from the clinical use of TNF-α inhibitors indicate that part of their anti-inflammatory effect may be dependent on their action on Tregs. Given the profusion of clinical trials testing cytokine administration or blocking to modulate inflammatory diseases, a better knowledge of the effects of cytokines on tTregs and pTregs biology is necessary to improve the efficiency of these immunotherapies.

Keywords: Foxp3; IL-2; TGF-β; TNF-α; pTreg; regulatory T cells; tTreg.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A hypothetic model for tTreg differentiation in the thymus. (A) Immature CD4+ thymocytes are engaged by strong agonist TCR/co-stimulatory signals, which results in the expression of the IL2R alpha chain CD25. (B) Subsequent interaction of immature tTreg precursors with CD122 signaling cytokines IL-2 and IL-15 leads to STAT5 phosphorylation to generate tTreg precursors. (C) Following continuous engagement of CD122, Foxp3 expression is induced in tTreg precursors to generate fully mature tTregs.
Figure 2
Figure 2
IL-2 favors the generation and increases the stability of the pTreg phenotype. (A) Activation of a naive conventional T cells through TCR stimulation and in the presence of TGF-β leads to generation of unstable pTregs that express moderate levels of Foxp3 and CD25. (B) In the presence of IL-2, pTregs increase the expression levels of Foxp3 and CD25 and the pTreg phenotype is stabilized. (C) During inflammation and in the absence of IL-2, the pTregs convert into “ex-pTregs” that can produce different pro-inflammatory cytokines, such as IFN-γ or IL-17 depending on the environmental context.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Almeida A. R., Zaragoza B., Freitas A. A. (2006). Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells. J. Immunol. 177, 192–200 - PubMed
    1. Biton J., Semerano L., Delavallee L., Lemeiter D., Laborie M., Grouard-Vogel G., et al. (2011). Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis. J. Immunol. 186, 3899–391010.4049/jimmunol.1003372 - DOI - PubMed
    1. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. (2004). A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36, 337–33810.1038/ng1323 - DOI - PubMed
    1. Burchill M. A., Yang J., Vang K. B., Moon J. J., Chu H. H., Lio C. W., et al. (2008). Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28, 112–12110.1016/j.immuni.2007.11.022 - DOI - PMC - PubMed
    1. Burchill M. A., Yang J., Vogtenhuber C., Blazar B. R., Farrar M. A. (2007). IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3(regulatory T cells. J. Immunol. 178, 280–290 - PubMed